Literature DB >> 9246624

Fabrication of stable packed capillary reversed-phase columns for protein structural analysis.

D Tong1, R L Moritz, J S Eddes, G E Reid, R K Rasmussen, D S Dorow, R J Simpson.   

Abstract

Capillary column (< or = 320-micron ID) liquid chromatography is an essential tool for the separation and concentration of low-picomole amounts of proteins and peptides for mass-spectrometric based structural analysis. We describe a detailed procedure for the fabrication of stable and efficient 50- to 180-micron ID polyimide fused-silica columns. Columns were packed by conventional slurry packing with reversed-phase silica-based supports followed by column bed consolidation with acetonitrile and sonication. PVDF membrane or internal fused-silica particles were employed for column end-frit construction. The ability of these columns to withstand high back pressures (300-400 bar) enabled their use for rapid chromatography (> 3400 cm/hr; i.e., approximately 40 microliters/min for 200-micron ID columns) and the loading of large sample volumes (up to 500 microliters). The accurate low flow rates (0.4-4.0 microliters/min) and precise gradient formation necessary to operate these columns were achieved by a simple modification of conventional HPLC systems [Moritz et al. (1992), J. Chromatogr. 599, 119-130]. Column performance was evaluated for ability to resolve low-fmol amounts of all components of a mixture of PTH-amino acids and to separate peptides for on-line LC/MS analysis of peptide mixtures derived from in situ digestion of 2-DE resolved protein spots.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246624     DOI: 10.1023/a:1026345023941

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  1 in total

1.  Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.

Authors:  A C Gill; M A Ritchie; L G Hunt; S E Steane; K G Davies; S P Bocking; A G Rhie; A D Bennett; J Hope
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.